2022 - Research.com Best Female Scientist Award
Her primary scientific interests are in Internal medicine, Transplantation, Surgery, Hematopoietic stem cell transplantation and Bone marrow. Her Internal medicine study integrates concerns from other disciplines, such as Gastroenterology, Oncology and Histocompatibility. Her work deals with themes such as Leukemia, Immunology and Human leukocyte antigen, which intersect with Transplantation.
The various areas that Mary M. Horowitz examines in her Leukemia study include Myeloid and Chronic phase chronic myelogenous leukemia. Her Hematopoietic stem cell transplantation research is multidisciplinary, incorporating perspectives in Case-control study, Total body irradiation, Hematopoietic stem cell, Transplantation Conditioning and Pediatrics. Her Bone marrow research is multidisciplinary, incorporating elements of Disease, Acute lymphocytic leukemia and Risk factor.
Mary M. Horowitz spends much of her time researching Internal medicine, Transplantation, Surgery, Hematopoietic stem cell transplantation and Oncology. In most of her Internal medicine studies, her work intersects topics such as Gastroenterology. Her Transplantation research includes themes of Hematopoietic cell, Human leukocyte antigen, Histocompatibility and Immunology.
As part of her studies on Surgery, Mary M. Horowitz often connects relevant areas like Transplantation Conditioning. Her Hematopoietic stem cell transplantation study incorporates themes from Retrospective cohort study, Myeloid leukemia, Myelodysplastic syndromes, Pediatrics and Cohort. Her Oncology research includes elements of Cancer and Bone marrow transplantation.
Mary M. Horowitz mainly focuses on Transplantation, Internal medicine, Clinical trial, Oncology and Hematopoietic cell. Her study in Transplantation focuses on Graft-versus-host disease in particular. Her work carried out in the field of Internal medicine brings together such families of science as Gastroenterology and Human leukocyte antigen.
Her work is dedicated to discovering how Oncology, Multiple myeloma are connected with Surgical oncology and Tolerability and other disciplines. The study incorporates disciplines such as Quality of life, Immunology and Marrow transplantation in addition to Hematopoietic cell. Her Hematopoietic stem cell transplantation research incorporates themes from Young adult, Survival analysis and Incidence.
Mary M. Horowitz mainly investigates Transplantation, Internal medicine, Hematopoietic stem cell transplantation, Oncology and Gastroenterology. A large part of her Transplantation studies is devoted to Graft-versus-host disease. Her study on Hematopoietic stem cell transplantation also encompasses disciplines like
Her studies in Oncology integrate themes in fields like Human leukocyte antigen, Disease and Immunotherapy. Clofarabine is closely connected to Total body irradiation in her research, which is encompassed under the umbrella topic of Gastroenterology. Mary M. Horowitz has included themes like Surgery and Propensity score matching in her Bone marrow study.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Graft-versus-leukemia reactions after bone marrow transplantation
MM Horowitz;RP Gale;PM Sondel;JM Goldman.
Evolving concepts in the management of chronic myeloid leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet
Michele Baccarani;Giuseppe Saglio;John Goldman;Andreas Hochhaus.
Chronic Myeloid Leukemia: An Update of Concepts and Management Recommendations of European LeukemiaNet
Michele Baccarani;Jorge Cortes;Fabrizio Pane;Dietger Niederwieser.
Journal of Clinical Oncology (2009)
High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation.
Stephanie J. Lee;John Klein;Michael Haagenson;Lee Ann Baxter-Lowe.
Outcomes after Transplantation of Cord Blood or Bone Marrow from Unrelated Donors in Adults with Leukemia
Mary J. Laughlin;Mary Eapen;Pablo Rubinstein;John E. Wagner.
The New England Journal of Medicine (2004)
Defining the intensity of conditioning regimens: working definitions.
Andrea Bacigalupo;Karen Ballen;Doug Rizzo;Sergio Giralt.
Biology of Blood and Marrow Transplantation (2009)
Graft-versus-host disease in children who have received a cord-blood or bone marrow transplant from an HLA-identical sibling. Eurocord and International Bone Marrow Transplant Registry Working Committee on Alternative Donor and Stem Cell Sources.
Vanderson Rocha;John E. Wagner;Kathleen A. Sobocinski;John P. Klein.
The New England Journal of Medicine (2000)
Lenalidomide after stem-cell transplantation for multiple myeloma
Philip L. McCarthy;Kouros Owzar;Craig C. Hofmeister;David D. Hurd.
The New England Journal of Medicine (2012)
Bone marrow transplantation for chronic myelogenous leukemia in chronic phase. Increased risk for relapse associated with T-cell depletion.
John M. Goldman;Robert Peter Gale;Mary M. Horowitz;James C. Biggs.
Annals of Internal Medicine (1988)
Solid Cancers after Bone Marrow Transplantation
Rochelle E. Curtis;Philip A. Rowlings;H. Joachim Deeg;Donna A. Shriner.
The New England Journal of Medicine (1997)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: